HERSHBERG ROBERT
Director
Sale 10b5-1
- Shares
- 100,000
- Price
- $4.96
- Value
- $496,000
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•38 filings
ATAI
AtaiBeckley Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$1,505,926
3 distinct insiders
Highlighted alerts
0
5 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get ATAI insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
ATAI overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
5
Voluntary view
P/S trades after deterministic checks
4
Administrative noise
Stored, never alerted
5
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- M
- Shares
- 51,142
- Price
- $1.35
- Footnotes
- 3
The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 7, 2026. The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $4.90 to $5.08. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. The stock option is fully vested.
Raspberry interpretation
Informational — no alert
Reason: administrative_code. The trade is reported under a Rule 10b5-1 plan.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Kochendoerfer Gerd
Chief Operating Officer
Sale 10b5-1
- Shares
- 50,000
- Price
- $5.00
- Value
- $250,000
Craig Kevin James
Chief Medical Officer
Sale 10b5-1
- Shares
- 42,579
- Price
- $4.51
- Value
- $192,031
Craig Kevin James
Chief Medical Officer
Sale 10b5-1
- Shares
- 42,579
- Price
- $5.00
- Value
- $212,895
Craig Kevin James
Chief Medical Officer
Sale 10b5-1
- Shares
- 100,000
- Price
- $3.55
- Value
- $355,000
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Jul 07, 2026 | HERSHBERG ROBERT Director | Sale | 100,000 | $4.96 | $496,000 | |
| Jun 26, 2026 | Kochendoerfer Gerd Chief Operating Officer | Sale | 50,000 | $5.00 | $250,000 | |
| Jun 25, 2026 | Craig Kevin James Chief Medical Officer | Sale | 42,579 | $4.51 | $192,031 | |
| Apr 20, 2026 | Craig Kevin James Chief Medical Officer | Sale | 42,579 | $5.00 | $212,895 | |
| Mar 20, 2026 | Craig Kevin James Chief Medical Officer | Sale | 100,000 | $3.55 | $355,000 |